Lead Ekstraksiyonu

Kusumoto, F.M., et al., 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart rhythm, 2017. 14(12): p. e503-e551.

Goldberger, Z. and R. Lampert, Implantable cardioverter-defibrillators: expanding indications and technologies. Jama, 2006. 295(7): p. 809-818.

Raatikainen, M.P., et al., Access to and clinical use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2016 Report from the European Heart Rhythm Association. Ep Europace, 2016. 18(suppl_3): p. iii1-iii79.

Greenspon, A.J., et al., Trends in permanent pacemaker implantation in the United States from 1993 to 2009: increasing complexity of patients and procedures. Journal of the American College of Cardiology, 2012. 60(16): p. 1540-1545.

Wilkoff, B., Heart Rhythm Society: American Heart Association: transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management. Heart Rhythm, 2009. 6: p. 1085-1104.

DeForge, W., Cardiac pacemakers: a basic review of the history and current technology. Journal of Veterinary Cardiology, 2019. 22: p. 40-50.

Beck, H., et al., 50th Anniversary of the first successful permanent pacemaker implantation in the United States: historical review and future directions. The American journal of cardiology, 2010. 106(6): p. 810-818.

Michalak, M., et al., Patient with DDD pacemaker and recurrent syncope–case report. Heart Beat Journal, 2017. 2: p. 12-14.

SHEPARD, R.B., et al., Pacing threshold spikes months and years after implant. Pacing and Clinical Electrophysiology, 1991. 14(11): p. 1835-1841.

Kistler, P.M., et al., Rapid decline in acute stimulation thresholds with steroid‐eluting active‐fixation pacing leads. Pacing and clinical electrophysiology, 2005. 28(9): p. 903-909.

Maytin, M., S.O. Jones, and L.M. Epstein, Long-term mortality after transvenous lead extraction. Circulation: Arrhythmia and Electrophysiology, 2012. 5(2): p. 252-257.

Esposito, M., et al., Morphologic and immunohistochemical observations of tissues surrounding retrieved transvenous pacemaker leads. Journal of Biomedical Materials Research: An Official Journal of The Society for Biomaterials, The Japanese Society for Biomaterials, and The Australian Society for Biomaterials and the Korean Society for Biomaterials, 2002. 63(5): p. 548-558.

Oto, A., et al., Percutaneous extraction of cardiac pacemaker and implantable cardioverter defibrillator leads with evolution mechanical dilator sheath: a single-centre experience. Europace, 2011. 13(4): p. 543-547.

Bongiorni, M.G., et al., 2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS. Ep Europace, 2018. 20(7): p. 1217-1217.

Varahan, U.L., V. Pretorius, and U. Birgersdotter-Green, Transvenous Lead Extraction: Step-by-Step Approach. The Journal of Innovations in Cardiac Rhythm Management, 2011. 2: p. 145-149.

Sadek, M.M., et al., Cardiovascular implantable electronic device lead extraction: evidence, techniques, results, and future directions. Current opinion in cardiology, 2016. 31(1): p. 23-28.

Habib, G., et al., 2015 ESC Guidelines for the management of infective endocarditis. Revista Española de Cardiología, 2016. 69(1).

Sandoe, J.A., et al., Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE). Journal of Antimicrobial Chemotherapy, 2015. 70(2): p. 325-359.

Bongiorni, M.G., et al., The European lead extraction controlled (ELECTRa) study: a European heart rhythm association (EHRA) registry of transvenous lead extraction outcomes. European heart journal, 2017. 38(40): p. 2995-3005.

Eckstein, J., et al., Necessity for surgical revision of defibrillator leads implanted long-term: causes and management. Circulation, 2008. 117(21): p. 2727-2733.

Hauser, R.G., et al., Early failure of a small-diameter high-voltage implantable cardioverter-defibrillator lead. Heart Rhythm, 2007. 4(7): p. 892-896.

Krahn, A.D., et al., Outcome of the Fidelis implantable cardioverter-defibrillator lead advisory: a report from the Canadian Heart Rhythm Society Device Advisory Committee. Heart Rhythm, 2008. 5(5): p. 639-642.

Swerdlow, C.D., et al., Downloadable software algorithm reduces inappropriate shocks caused by implantable cardioverter-defibrillator lead fractures: a prospective study. Circulation, 2010. 122(15): p. 1449-1455.

Ellenbogen, K.A., et al., Performance of Lead Integrity Alert to assist in the clinical diagnosis of implantable cardioverter defibrillator lead failures: analysis of different implantable cardioverter defibrillator leads. Circulation: Arrhythmia and Electrophysiology, 2013. 6(6): p. 1169-1177.

Sung, R.K., et al., Long-term electrical survival analysis of Riata and Riata ST silicone leads: National Veterans Affairs experience. Heart Rhythm, 2012. 9(12): p. 1954-1961.

Koneru, J.N., et al., Diagnosis of high-voltage conductor fractures in Sprint Fidelis leads. Heart Rhythm, 2013. 10(6): p. 813-818.

Valentino, V., et al., An unusual interaction between an abandoned pacing lead and an ICD lead. Heart rhythm, 2015. 12(6): p. 1400-1401.

Pfitzner, P. and H.J. TRAPPE, Oversensing in a cardioverter defibrillator system caused by interaction between two endocardial defibrillation leads in the right ventricle. Pacing and clinical electrophysiology, 1998. 21(4): p. 764-768.

FU, H.X., et al., Outcome and management of pacemaker‐induced superior vena cava syndrome. Pacing and Clinical Electrophysiology, 2014. 37(11): p. 1470-1476.

Riley, R.F., et al., Managing superior vena cava syndrome as a complication of pacemaker implantation: a pooled analysis of clinical practice. Pacing and clinical electrophysiology, 2010. 33(4): p. 420-425.

Lickfett, L., et al., Incidence of venous obstruction following insertion of an implantable cardioverter defibrillator. A study of systematic contrast venography on patients presenting for their first elective ICD generator replacement. EP Europace, 2004. 6(1): p. 25-31.

Burri, H., Overcoming the challenge of venous occlusion for lead implantation. Indian pacing and electrophysiology journal, 2015. 15(2): p. 110-112.

Sohal, M., et al., Laser lead extraction to facilitate cardiac implantable electronic device upgrade and revision in the presence of central venous obstruction. Europace, 2014. 16(1): p. 81-87.

Gula, L.J., et al., Central venous occlusion is not an obstacle to device upgrade with the assistance of laser extraction. Pacing and clinical electrophysiology, 2005. 28(7): p. 661-666.

Indik, J.H., et al., 2017 HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices. Heart Rhythm, 2017. 14(7): p. e97-e153.

Lee, J.C., et al., ICD lead proarrhythmia cured by lead extraction. Heart Rhythm, 2009. 6(5): p. 613-618.

Migliore, F., et al., Incidence, management, and prevention of right ventricular perforation by pacemaker and implantable cardioverter defibrillator leads. Pacing and Clinical Electrophysiology, 2014. 37(12): p. 1602-1609.

Polewczyk, A., et al., Lead dependent tricuspid dysfunction: analysis of the mechanism and management in patients referred for transvenous lead extraction. Cardiology journal, 2013. 20(4): p. 402-410.

Bracke, F.A., L. Dekker, and B.M. van Gelder, The Needle's Eye Snare as a primary tool for pacing lead extraction. Europace, 2013. 15(7): p. 1007-1012.

Bongiorni, M.G., et al., Safety and efficacy of internal transjugular approach for transvenous extraction of implantable cardioverter defibrillator leads. Europace, 2014. 16(9): p. 1356-1362.

Epstein, L.M. and M. Maytin, Strategies for transvenous lead extraction procedures. The Journal of Innovations in Cardiac Rhythm Management, 2017. 8(5): p. 2702.

Mazzone, P., et al., Safety and efficacy of the new bidirectional rotational Evolution® mechanical lead extraction sheath: results from a multicentre Italian registry. Ep Europace, 2018. 20(5): p. 829-834.

Kennergren, C., et al., Laser-assisted lead extraction: the European experience. Europace, 2007. 9(8): p. 651-656.

Love, C.J., Lead management and lead extraction. Cardiac Electrophysiology Clinics, 2018. 10(1): p. 127-136.

Tsang, D.C., et al., Long-term outcomes of prophylactic placement of an endovascular balloon in the vena cava for high-risk transvenous lead extractions. Heart Rhythm, 2017. 14(12): p. 1833-1838.

Kusumoto, F.M., et al., 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart rhythm, 2017. 14(12): p. e503-e551.

Goldberger, Z. and R. Lampert, Implantable cardioverter-defibrillators: expanding indications and technologies. Jama, 2006. 295(7): p. 809-818.

Raatikainen, M.P., et al., Access to and clinical use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2016 Report from the European Heart Rhythm Association. Ep Europace, 2016. 18(suppl_3): p. iii1-iii79.

Greenspon, A.J., et al., Trends in permanent pacemaker implantation in the United States from 1993 to 2009: increasing complexity of patients and procedures. Journal of the American College of Cardiology, 2012. 60(16): p. 1540-1545.

Wilkoff, B., Heart Rhythm Society: American Heart Association: transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management. Heart Rhythm, 2009. 6: p. 1085-1104.

DeForge, W., Cardiac pacemakers: a basic review of the history and current technology. Journal of Veterinary Cardiology, 2019. 22: p. 40-50.

Beck, H., et al., 50th Anniversary of the first successful permanent pacemaker implantation in the United States: historical review and future directions. The American journal of cardiology, 2010. 106(6): p. 810-818.

Michalak, M., et al., Patient with DDD pacemaker and recurrent syncope–case report. Heart Beat Journal, 2017. 2: p. 12-14.

SHEPARD, R.B., et al., Pacing threshold spikes months and years after implant. Pacing and Clinical Electrophysiology, 1991. 14(11): p. 1835-1841.

Kistler, P.M., et al., Rapid decline in acute stimulation thresholds with steroid‐eluting active‐fixation pacing leads. Pacing and clinical electrophysiology, 2005. 28(9): p. 903-909.

Maytin, M., S.O. Jones, and L.M. Epstein, Long-term mortality after transvenous lead extraction. Circulation: Arrhythmia and Electrophysiology, 2012. 5(2): p. 252-257.

Esposito, M., et al., Morphologic and immunohistochemical observations of tissues surrounding retrieved transvenous pacemaker leads. Journal of Biomedical Materials Research: An Official Journal of The Society for Biomaterials, The Japanese Society for Biomaterials, and The Australian Society for Biomaterials and the Korean Society for Biomaterials, 2002. 63(5): p. 548-558.

Oto, A., et al., Percutaneous extraction of cardiac pacemaker and implantable cardioverter defibrillator leads with evolution mechanical dilator sheath: a single-centre experience. Europace, 2011. 13(4): p. 543-547.

Bongiorni, M.G., et al., 2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS. Ep Europace, 2018. 20(7): p. 1217-1217.

Varahan, U.L., V. Pretorius, and U. Birgersdotter-Green, Transvenous Lead Extraction: Step-by-Step Approach. The Journal of Innovations in Cardiac Rhythm Management, 2011. 2: p. 145-149.

Sadek, M.M., et al., Cardiovascular implantable electronic device lead extraction: evidence, techniques, results, and future directions. Current opinion in cardiology, 2016. 31(1): p. 23-28.

Habib, G., et al., 2015 ESC Guidelines for the management of infective endocarditis. Revista Española de Cardiología, 2016. 69(1).

Sandoe, J.A., et al., Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE). Journal of Antimicrobial Chemotherapy, 2015. 70(2): p. 325-359.

Bongiorni, M.G., et al., The European lead extraction controlled (ELECTRa) study: a European heart rhythm association (EHRA) registry of transvenous lead extraction outcomes. European heart journal, 2017. 38(40): p. 2995-3005.

Eckstein, J., et al., Necessity for surgical revision of defibrillator leads implanted long-term: causes and management. Circulation, 2008. 117(21): p. 2727-2733.

Hauser, R.G., et al., Early failure of a small-diameter high-voltage implantable cardioverter-defibrillator lead. Heart Rhythm, 2007. 4(7): p. 892-896.

Krahn, A.D., et al., Outcome of the Fidelis implantable cardioverter-defibrillator lead advisory: a report from the Canadian Heart Rhythm Society Device Advisory Committee. Heart Rhythm, 2008. 5(5): p. 639-642.

Swerdlow, C.D., et al., Downloadable software algorithm reduces inappropriate shocks caused by implantable cardioverter-defibrillator lead fractures: a prospective study. Circulation, 2010. 122(15): p. 1449-1455.

Ellenbogen, K.A., et al., Performance of Lead Integrity Alert to assist in the clinical diagnosis of implantable cardioverter defibrillator lead failures: analysis of different implantable cardioverter defibrillator leads. Circulation: Arrhythmia and Electrophysiology, 2013. 6(6): p. 1169-1177.

Sung, R.K., et al., Long-term electrical survival analysis of Riata and Riata ST silicone leads: National Veterans Affairs experience. Heart Rhythm, 2012. 9(12): p. 1954-1961.

Koneru, J.N., et al., Diagnosis of high-voltage conductor fractures in Sprint Fidelis leads. Heart Rhythm, 2013. 10(6): p. 813-818.

Valentino, V., et al., An unusual interaction between an abandoned pacing lead and an ICD lead. Heart rhythm, 2015. 12(6): p. 1400-1401.

Pfitzner, P. and H.J. TRAPPE, Oversensing in a cardioverter defibrillator system caused by interaction between two endocardial defibrillation leads in the right ventricle. Pacing and clinical electrophysiology, 1998. 21(4): p. 764-768.

FU, H.X., et al., Outcome and management of pacemaker‐induced superior vena cava syndrome. Pacing and Clinical Electrophysiology, 2014. 37(11): p. 1470-1476.

Riley, R.F., et al., Managing superior vena cava syndrome as a complication of pacemaker implantation: a pooled analysis of clinical practice. Pacing and clinical electrophysiology, 2010. 33(4): p. 420-425.

Lickfett, L., et al., Incidence of venous obstruction following insertion of an implantable cardioverter defibrillator. A study of systematic contrast venography on patients presenting for their first elective ICD generator replacement. EP Europace, 2004. 6(1): p. 25-31.

Burri, H., Overcoming the challenge of venous occlusion for lead implantation. Indian pacing and electrophysiology journal, 2015. 15(2): p. 110-112.

Sohal, M., et al., Laser lead extraction to facilitate cardiac implantable electronic device upgrade and revision in the presence of central venous obstruction. Europace, 2014. 16(1): p. 81-87.

Gula, L.J., et al., Central venous occlusion is not an obstacle to device upgrade with the assistance of laser extraction. Pacing and clinical electrophysiology, 2005. 28(7): p. 661-666.

Indik, J.H., et al., 2017 HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices. Heart Rhythm, 2017. 14(7): p. e97-e153.

Lee, J.C., et al., ICD lead proarrhythmia cured by lead extraction. Heart Rhythm, 2009. 6(5): p. 613-618.

Migliore, F., et al., Incidence, management, and prevention of right ventricular perforation by pacemaker and implantable cardioverter defibrillator leads. Pacing and Clinical Electrophysiology, 2014. 37(12): p. 1602-1609.

Polewczyk, A., et al., Lead dependent tricuspid dysfunction: analysis of the mechanism and management in patients referred for transvenous lead extraction. Cardiology journal, 2013. 20(4): p. 402-410.

Bracke, F.A., L. Dekker, and B.M. van Gelder, The Needle's Eye Snare as a primary tool for pacing lead extraction. Europace, 2013. 15(7): p. 1007-1012.

Bongiorni, M.G., et al., Safety and efficacy of internal transjugular approach for transvenous extraction of implantable cardioverter defibrillator leads. Europace, 2014. 16(9): p. 1356-1362.

Epstein, L.M. and M. Maytin, Strategies for transvenous lead extraction procedures. The Journal of Innovations in Cardiac Rhythm Management, 2017. 8(5): p. 2702.

Mazzone, P., et al., Safety and efficacy of the new bidirectional rotational Evolution® mechanical lead extraction sheath: results from a multicentre Italian registry. Ep Europace, 2018. 20(5): p. 829-834.

Kennergren, C., et al., Laser-assisted lead extraction: the European experience. Europace, 2007. 9(8): p. 651-656.

Love, C.J., Lead management and lead extraction. Cardiac Electrophysiology Clinics, 2018. 10(1): p. 127-136.

Tsang, D.C., et al., Long-term outcomes of prophylactic placement of an endovascular balloon in the vena cava for high-risk transvenous lead extractions. Heart Rhythm, 2017. 14(12): p. 1833-1838.